# ImmunityBio, Inc.: Form SC 13D/A, filed Dec 7, 2022

- Company: [ImmunityBio, Inc.](/companies/ibrx.md) (CIK 1326110)
- Form: SC 13D/A
- Filed: 2022-12-07
- Accepted by EDGAR: Dec 6, 2022, 20:28 ET
- Period: not reported
- Accession: 0001193125-22-299573
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1326110/000119312522299573/d413120dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326110/000119312522299573/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326110/000119312522299573/d413120dsc13da.htm

Filed Dec 7, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-299573. Last ingested by Listed: Nov 9, 2026, 17:45 ET. No prices; not investment advice.
